Article Text

PDF

A3.16 Specific Overexpression of Synovial Interleukin-21+ CD4+ T Cells Co-Expressing Tumour Necrosis Factor in Rheumatoid Arthritis: Role in Joint Destruction?
  1. M Cristina Lebre1,2,
  2. Pedro L Vieira3,
  3. Saida Aarrass1,2,
  4. Thomas Newsom-Davis3,
  5. Paul P Tak1,
  6. Gavin R Screaton3
  1. 1Division of Clinical Immunology and Rheumatology
  2. 2Department Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands
  3. 3Department of Immunology, Imperial College London, Hammersmith Campus, London, UK

Abstract

Background and Objectives IL-21 is a cytokine produced by activated CD4+ T cells and T follicular helper cells (TFh) that has been implicated in several autoimmune diseases. IL-21 regulates antibody production by B cells and induces osteoclastogenesis, mechanisms that contribute to rheumatoid arthritis (RA) pathology. Importantly, IL-21R blockade ameliorates arthritis in mice. Here we investigated the functional characteristics of CD4+IL-21+ T cells in RA.

Materials and Methods We evaluated the expression of surface markers and cytokine production in matched peripheral blood (PB) and synovial fluid (SF) from 13 RA and 6 psoriatic arthritis (PsA) patients, and PB of 17 healthy control (HC) subjects by flow cytometry following PMA/Ionomycin stimulation ex-vivo. IL-21 concentrations were assessed by ELISA in cell-free SF samples of RA (n = 15), PsA (n = 14) and OA (n = 6) patients and in synovial biopsy culture supernatants (6 days) of RA (n = 6) and ankylosing spondylitis (AS; n = 5) patients. The effects of IL-21 were evaluated on cytokine and matrix metalloproteinase (MMP) release by RA synovial biopsies.

Results The frequency of IL-21+CD4+ T cells in RA and PsA SF was significantly higher compared to PB (P < 0.0001 and P < 0.0001, respectively). Moreover, the frequency of both total IL-21+CD4+ (P = 0.0140) and IL-21+TNF+CD4+ T cells (P = 0.0038) in RA SF were significantly increased compared to PsA patients. The frequency of IL-21+CD4+ T cells in RA PB was positively correlated with DAS28 (r = 0.592, P = 0.033), serum anti-cyclic citrullinated peptide (anti-CCP) antibodies (r = 0.788, P = 0.001) and IgM-rheumatoid factor (IgM-RF; r = 0.691, P = 0.009). In addition, the percentage of IL-21+CD4+ T cells in anti-CCP+ or IgM-RF+ patients was significantly higher compared to anti-CCP- (P = 0.03) and IgM-RF- (P = 0.01) patients respectively. In addition to PB and SF, we found IL-21+CD4+ T cells present in RA synovial tissue. Significant higher levels of IL-21 in RA SF compared to OA SF (P = 0.04) were observed confirming previous observations. RA synovial biopsies released significantly higher levels of IL-21 compared to biopsies from AS patients. The levels of IL-21 in SF were associated with CRP and with the MMP-1 and MMP-3. Related to this, IL-21 selectively induced MMP-1 and MMP-3 secretion by RA synovial biopsies. Synovial IL-21+CD4+ T cells did not phenotypically fit the TFh cell paradigm in that they did not express CXCR5 and ICOS.

Conclusions The results of this study support the notion that IL-21-producing CD4 T cells are involved in promoting synovial inflammation (TNF) and joint destruction (MMP) in RA and might be a therapeutic target in this disease.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.